3D Cell Culture Market to grow at a CAGR of 16.6% during 2024-2028
The 3D Cell Culture Market is expected to grow at a CAGR of 16.6% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 1382.4 million. Monoclonal antibodies, derived from identical immune cells, are a significant growth driver in the pharmaceutical sector due to their extensive applications in biology, diagnostic imaging, medicine, and biochemistry. These applications span various medical fields, including oncology, neurology, and inflammatory diseases, such as cancer, multiple sclerosis, rheumatoid arthritis, cardiovascular diseases, Crohn's disease, psoriasis, and ulcerative colitis. The escalating demand for monoclonal antibodies, driven by the increasing prevalence of chronic diseases and other health concerns, necessitates the development and provision of advanced production technologies. Large-scale manufacturing plants, equipped with numerous 3D cell culture bioreactors for antibody production, have been established by leading industry players, propelling the global 3D cell culture market expansion.
Get more information on 3D Cell Culture Market by requesting a sample report
Technavio analysts predict that the Cancer and stem cell research subsegment will lead the Application segment during 2024 and 2028 The 3D cell culture market is experiencing significant growth due to the increasing demand for advanced research and development in the biotechnology sector. Three-dimensional cell cultures offer numerous advantages over traditional 2D cultures, including improved cellular functionality and better representation of in vivo conditions. Key players in this market are investing heavily in research and development to expand their product offerings and meet the growing demand. The market is expected to continue its robust growth trajectory in the coming years.
Here are the various ways based on which the market is segmented:
There are several factors that are causing the market to flourish increase in infectious diseases
Learn which are the obstacles that the market is experiencing in the way of its growth by accessing the free PDF report
The global 3D cell culture market is experiencing significant growth due to the increasing demand for advanced research techniques and innovative pharmaceutical products. Three-dimensional cell culture techniques have revolutionized the way cells are grown and studied in laboratories, offering a more physiologically relevant environment compared to traditional 2D cultures. Key players in the market are developing a range of 3D cell culture products, including scaffolds and growth media, to support the growth and differentiation of various cell types. These products find applications in various fields such as drug discovery, toxicology testing, and tissue engineering. The development of 3D cell culture technology is driven by the need for more accurate and predictive research models, as well as the potential to create functional tissue constructs for therapeutic applications. Biotechnology companies and research institutions are investing heavily in this area, driving innovation and expanding the market. The global 3D cell culture market is expected to continue growing in the coming years, as more researchers and pharmaceutical companies adopt this technology to advance their research and product development efforts. Overall, the future of 3D cell culture looks bright, with numerous opportunities for growth and innovation in this exciting field.
The global life sciences tools and services market, a significant segment of the parent life science industry, encompasses companies and offerings involved in the research and development (R&D) of various product categories, such as capital equipment, instruments, accessories, and consumables. These products are utilized in the production of pharmaceuticals, biotechnology products, and laboratory diagnosis for various diseases. Additionally, the market includes life sciences-related services, including contract research, manufacturing, and sales. According to Technavio, the global healthcare market size is determined by the consolidated revenue generated by manufacturers of equipment, supplies, pharmaceuticals, biotechnology, and life science tools and services. The market's expansion will be fueled by the increasing global population aging, with a projected rise in the proportion of individuals over 60 years old.
The 3D Cell Culture Market is experiencing significant growth, fueled by the increase in infectious diseases. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/